SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Neurobiological Tech (NTII)
NTII 0.00010000.0%Mar 7 3:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Sam Quentin who wrote (192)11/22/1997 1:44:00 AM
From: John Dwyer  Read Replies (2) of 1494
 
No news that I know of. Lots of uncertainty and so investors
steer clear. The chart of this stock looks like crap too. I'm
hoping that higher volume and a low stock price indicates some
kind of capitulation...

Things look bleak right now... they need cash very badly. They
need a deal or some kind of stock deal... either floating new
shares to the public or a private placement. Anything to keep
them afloat. My guess is that a partnership is in the works. They
need big bucks or a partner to do Phase III trials on memantine
and I really don't think they can offer enough shares to fund
that kind of study. If the Phase II data looks good maybe Freiman
can pull it off... that should give NTII a huge boost. Let's hope
so....

John
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext